Influence of tidal volume on pulmonary NO release, tissue lipid peroxidation and surfactant phospholipids  by Hammerschmidt, Stefan et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1639 (2003) 17–26Influence of tidal volume on pulmonary NO release, tissue lipid
peroxidation and surfactant phospholipids
Stefan Hammerschmidta,*,1, Ju¨rgen Schillerb,1, Hartmut Kuhna, Michael Meybauma,
Christian Gessnera, Torsten Sandvoßa, Klaus Arnoldb, Hubert Wirtza
aDepartment of Pulmonary Medicine, Critical Care and Cardiology, Medical Department, University of Leipzig, Leipzig, Germany
b Institute of Medical Physics and Biophysics, Medical Department, University of Leipzig, Leipzig, GermanyReceived 7 January 2003; received in revised form 26 June 2003; accepted 21 July 2003Abstract
Mechanical stress during ventilation may cause or aggravate acute lung injury. This study investigates the influence of low vs. high tidal
volume (Vt) on factors known to play key roles in acute lung injury: nitric oxide release, eNOS and iNOS gene expression, lipid peroxidation
(LPO), and surfactant phospholipids (PL). Isolated rabbit lungs were subjected to one of three ventilation patterns for 135 min (Vt-PEEP): 6 ml/
kg–0 cm H2O, 12 ml/kg–0 cm H2O, 6 ml/kg–5 cm H2O. 12 ml/kg–0 cm H2O and 6 ml/kg–5 cm H2O resulted in comparable peak
inspiratory pressure (PIP). This allowed comparing low and high Vt without dependence on PIP. Ventilatory patterns did not induce changes in
pulmonary artery pressure, vascular permeability (Kf,c), PIP or pulmonary compliance. High Vt in comparison with both of the low Vt groups
caused an increase in BALF-nitrite (30.6F 3.0* vs. 21.4F 2.2 and 16.2F 3.3 AM), BALF-PL (1110F 19* vs. 750F 68 and 634F 82 Ag/ml),
and tissue LPO product accumulation (0.62F 0.051* vs. 0.48F 0.052 and 0.43F 0.031 nmol/mg), *P < 0.05 each. Perfusate nitrite and
BALF-PL composition (assessed by use of 31P-NMR spectroscopy and MALDI-TOF mass spectrometry) did not differ among the groups.
High Vt ventilation reduced eNOS gene expression but did not affect iNOS expression. The increased release of NO and the accumulation of
LPO products may represent early lung injury while elevated BALF-PL may reflect distension-induced surfactant secretion.
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Mechanical ventilation is an invaluable measure of main-
taining sufficient arterial oxygenation in patients with respi-
ratory failure. However, mechanical ventilation may also
aggravate or perpetuate acute lung injury [1,2]. Ventilatory
strategies have been recognized to be crucial for patient
outcome [3,4]. Mechanical stress associated with alveolar
overdistension due to high tidal volume (Vt) and high trans-
pulmonary pressure has been identified as the predominant
factor in the pathogenesis of VILI [5]. More recently, clinical
[6] and experimental [7,8] studies have investigated mechan-
ically induced release of cytokines, one of several biological0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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1 Both authors contributed equally to the study.effects induced by mechanical stimulation (for review see:
Ref. [9]). An imbalance of mediators such as cytokines may
induce the systemic effects of severe acute lung injury and
determine prognosis.
Other physiological processes, e.g. pulmonary surfactant
secretion and endogenous nitric oxide release, may be
altered by mechanical stimuli: (i) acute lung injury and
even more so the acute respiratory distress syndrome
(ARDS) are characterized by surfactant dysfunction and
surfactant phospholipid deficiency [10–12]. Surfactant
phospholipid deficiency may result from injury to alveolar
type II cells. Surfactant dysfunction is caused predominant-
ly by inactivation of surfactant by protein components such
as fibrinogen [13]. Because phospholipid secretion of
alveolar type II cells in primary culture is stimulated by
mechanical distension [14,15], the pattern of alveolar infla-
tion/deflation, i.e. the ventilatory strategy may also affect
the alveolar surfactant content and composition. (ii) Inha-
lative nitric oxide has been shown to induce a selective
pulmonary vasodilatation with improved perfusion of well-
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and improved oxygenation [16,17]. However, nitric oxide
has also been shown to aggravate lung damage in con-
ditions with increased oxidant generation, such as acute
lung injury by peroxynitrite formation [18,19]. This has
been referred to as ‘‘nitrosative stress’’. Increased nitric
oxide concentrations in bronchoalveolar lavage (BAL) fluid
measured as nitrite and nitrate have been found in patients
at risk for and with ARDS and have been related to
increased mortality [20]. Pulmonary nitric oxide is released
by the activity of a constitutive nitric oxide synthase (NOS,
the endothelial isoform of NOS, eNOS) [21,22] and by an
inducible NOS isoform (iNOS) [23,24]. The latter is in-
duced by inflammatory cytokines with or without LPS
exposure [23,24]. iNOS could also be induced by mechan-
ical stimulation either directly or indirectly by resulting
inflammatory mechanisms.
Clinical trials have mainly focussed on the comparison
between low and high Vt and resulted in inconsistent effects
of lung-protective ventilatory strategies [3,4]. The ARDSnet
study demonstrated decreased mortality in patients ventilat-
ed with low (6 ml/kg) vs. high (12 ml/kg) Vt and a limitation
of the inspiratory plateau pressure to 30 vs. 50 cm H2O,
respectively.
Paralleling the ARDSnet study design, the Vt in this study
were tailored accordingly. This study investigates the influ-
ence of Vt during mechanical ventilation on surfactant
phospholipid concentration and composition, on alveolar
and vascular NO release, on eNOS and iNOS gene expres-
sion as well as on tissue lipid peroxidation (LPO) product
accumulation.2. Methods
2.1. Substances
Perfusate for isolated lungs was obtained from Serag
Wiessner (Naila, Germany). Chemicals for buffer prepara-
tion (NaCl, KH2PO4 and Na2HPO4), solvents (chloroform
and methanol), matrix compounds (2,5-dihydroxybenzoic
acid [DHB] as well as sinapinic acid and a-cyano-4-
hydroxycinamic acid for comparative purposes) and tri-
fluoroacetic acid were obtained in highest purity from Fluka
Feinchemikalien GmbH (Neu-Ulm, Germany). All chem-
icals for NMR spectroscopy (D2O with an isotopic purity of
99.96%, CDCl3 with 99.98%, and sodium cholate as well as
EDTA) were also obtained from Fluka.
2.2. Isolated lung model—general procedure
Preparation of isolated rabbit lungs was performed using
the method described in detail by Seeger et al. [25]. Rabbits of
either sex between 2.0 and 2.5 kg were used. The lungs were
ventilated with 4% CO2, 17% O2, 79% N2 to maintain the
perfusate pH value between 7.37 and 7.40. Lungs wereventilated using a rodent animal respirator (FMI GmbH,
Seeheim, Germany). Vt and PEEP were selected according
to the experimental group. Ventilation frequency was 30
min 1. PEEP was set at 2 cm H2O during preparation.
Perfusate flow was gradually increased to the final flow rate
of 100 mlmin 1 with recirculation of the buffer medium
(total circulating volume 300 ml: NaCl, 125 mM; KCl, 4.3
mM; KH2PO4, 1.1 mM; NaHCO3, 25 mM; CaCl2, 2.4 mM;
MgCl2, 1.3 mM; glucose, 13.3 mM). Perfusate temperature
was 37 jC. Pulmonary arterial pressure (PAP), pulmonary
venous pressure, ventilatory pressure (PV) and the weight
gain of the isolated organ were continuously recorded.
Following a steady state period, only those lungs were
selected for the study that fulfilled the entry conditions:
absence of leakage, a homogeneous white appearance, lack
of edema, and constant lung weight. The lungs were placed in
a humid chamber (glass, temperature controlled). Pulmonary
venous pressure was adjusted to 2 mm Hg.
2.3. Hydrostatic challenge
Capillary filtration coefficient (Kf,c) was determined gravi-
metrically from the slope of lung weight gain after a sudden
venous pressure elevation of 10 cm H2O for 8 min [26]. Kf,c
was expressed as 10 4ml s 1 cm H2O 1 g 1.
The total rapid change in weight over the first 2 min
following the onset of the venous pressure rise was desig-
nated as pure vascular filling and used for the calculation of
vascular compliance (C, [g cm H2O 1]) [26].
Retention (DW, [g]) was determined as the net difference
in weight before and after a hydrostatic challenge.
2.4. Pressure–volume curves
Pressure–volume curves ( p–V curves) were obtained by
gradually increasing Vt from 1 ml/kg to a maximum Vt of 12
ml/kg in steps of 1 ml/kg every 30 s and then reducing
accordingly to 1 ml/kg. This procedure was repeated twice.
PV was continuously recorded. Thirty seconds were allowed
for the peak inspiratory pressure (PIP) to reach a new steady
state at each step. This PIP was used for the p–V curves.
2.5. Experimental protocol
p–V curves were obtained in a separate set of seven
lungs immediately after lung preparation and warm up.
These p–V curves were taken as baseline p–V curves and
used for comparison with p–V curves obtained after the
entire recording time.
The ventilation patterns were adjusted at the beginning of
a 45 min steady state period. Lungs were subjected to one of
three ventilation patterns (n = 8 lungs each group). A base-
line hydrostatic challenge was performed during the last 15
min of this steady state period. Hydrostatic challenges were
performed at 30, 60, 90 and 120 min. PAP and PIP were
continuously recorded. The experiments were terminated
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each ventilation pattern group at 135 min. BAL and tissue
sampling were performed in the remaining four lungs of
each ventilation pattern group at t= 135 min. BAL fluid was
analyzed for nitrite concentration, total phospholipid con-
centration, phospholipid composition and LDH activity.
Tissue was analyzed for eNOS and iNOS gene expression
and LPO products. Perfusate samples drawn at 135 min
were analyzed for nitrite concentration. Perfusate samples
drawn immediately prior to each hydrostatic challenge were
analyzed for potassium concentration and LDH activity to
detect cellular damage.
2.6. Ventilation patterns
Ventilation patterns were defined primarily to allow a
comparison between low and high Vt without dependence
on PIP. Ventilator frequency was constant at 30 min 1.
The ventilation patterns were selected based on p–V
curves measured in a separate set of seven isolated lungs.
These p–V curves characterized the ventilatory mechanics
in this ex vivo preparation. Tidal volumes of 6 and 12 ml/
kg were selected for low and high Vt ventilation, respec-
tively, without PEEP (LVZP and HVZP groups). A low Vt
of 6 ml/kg and an added PEEP of 5 cm H2O were applied
in a third group (LV5P). Using p–V curves, this PEEP
was found to be above the lower inflection point of the
p–V curves and to cause a PIP similar to that caused by
the larger Vt in the HVZP group when added to the low Vt
of 6 ml/kg.
2.7. Bronchoalveolar lavage
Lavage was performed at the end of the experiment
after clamping the left main bronchus. Lavage of the
right lung only was performed by tracheal instillation of
25 ml (2 12.5 ml) saline. Recovery was approximately
15 ml in all experiments. There were no differences in
recovery among the experimental groups. Lavage was
centrifuged and the supernatant was stored at  80 jC
and used for measurements of nitrite and LDH concen-
trations as well as for subsequent extractions of phos-
pholipids. Lipid extraction was performed in all cases
according to the Bligh and Dyer [27] procedure using a
ratio of 1:1:0.9 (v/v/v) of chloroform/methanol/aqueous
sample.
2.8. BAL fluid phospholipid concentration and phospholipid
composition
Lipid extracts of BAL fluid were analyzed for total
phospholipid concentration as described by Stewart [28].
Dipalmitoyl-phosphatidylcholine was used for recording
the master curve. This assay primarily detects phosphati-
dylcholine, whereas the sensitivity for other phospholipids
is lower. Since phosphatidylcholine constitutes the major-ity of phospholipids in BAL, we used this assay instead of
the more time-consuming phosphate assay.
2.9. MALDI-TOF mass spectrometry
Organic extracts of BAL fluids were directly applied on
the sample plate as 1 Al droplets, followed by the addition of
1 Al matrix solution. For all samples a 0.5 M 2,5-DHB
solution in methanol containing 0.1% trifluoroacetic acid
was used. This matrix was shown to provide the best results
with lipids and phospholipids [29]. Subsequently, samples
were rapidly crystallized under a warm stream of air.
All MALDI-TOF mass spectra were acquired on a
Voyager Biospectrometry DE workstation (PerSeptive Bio-
systems, Framingham, MA, USA). The system utilizes a
pulsed nitrogen laser, emitting at 337 nm. The extraction
voltage was 20 kV and the ‘‘low-mass gate’’ was turned
on to prevent the saturation of the detector by ions
resulting from the matrix [29]. One hundred and twenty-
eight single laser shots were averaged for each mass
spectrum. The laser strength was kept about 10% above
threshold to obtain the best signal to noise ratio. In order
to enhance the spectral resolution, all spectra were ac-
quired in the reflector mode. Both, positive and negative
ion spectra were acquired.
2.10. NMR spectroscopy
For 31P-NMR spectroscopy di-lauroyl-phosphatidic acid
(PA 12:0/12:0) was added into organic extracts of BAL
fluids as an internal standard. The final concentration was
47.2 AM. Organic extracts of BAL fluids were evaporated to
dryness in a centrifugal evaporator (Jouan, Germany). The
residue was subsequently redissolved in deuterated water
containing 200 mM sodium cholate and 5 mM EDTA.
31P-NMR spectra were recorded on a Bruker DRX-600
spectrometer operating at 242.94 MHz for 31P. All measure-
ments were performed on 0.6ml samples in 5mmNMR tubes
using a 5 mm ‘‘direct’’ broadband probe at 37 jC. Composite
pulse decoupling (Waltz-16) was applied to eliminate 31P–1H
coupling and the ‘‘inverse-gated’’ pulse sequence was used to
eliminate the effects of nuclear Overhauser effect. Other
NMR parameters were as follows: transient-acquisition time:
1 s, data size: 16 K, 60j pulse (5 As), pulse delay 2 s. A line
broadening of 0.5 Hz was applied for the processing of the
free induction decays. Spectra were analyzed using Bruker
WinNMR.
2.11. LPO products
Frozen lung tissue of the left lungs (stored at  80 jC)
was homogenized in ice-cold buffer using a turrax device
(T25 basic ultra turrax, Stauffen, Germany). The homoge-
nates were centrifuged at 3000 g for 5 min at 4 jC.
Supernatant was assayed for LPO products. The tissue
content of the LPO products, i.e. malondialdehyde (MDA)
Fig. 1. PIP (upper panel) and PAP (lower panel) of the three different
experimental groups are plotted against the recording time.
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commercial assay (Calbiochem-Novabiochem GmbH,
Schwalbach, Germany) based on a chromogenic reaction,
with MDA and 4-HDA at 45 jC yielding a stable chromo-
phore with a maximum absorption at a wavelength of 586
nm. The concentration of LPO products in tissue homoge-
nate was related to tissue mass (LPO products [nmolmg
lung tissue 1]).
2.12. BAL fluid and perfusate nitrite concentration
Griess reagent (400 Al) was added to 400 Al sample
volume. The mixture was incubated for 20 min at room
temperature. Extinction was read at 550 nm. Sodium nitrite
was used as a standard [30].
2.13. Potassium and LDH activity
Potassium and LDH were determined in the perfusate in
order to exclude cellular damage. Potassium and lactate
dehydrogenase (LDH) measurements were performed by
standard automated assays.
2.14. RT-PCR for iNOS and eNOS gene expression
Total RNA was isolated using the RNeasy Mini Kit
(Quiagen). RNA (1 Ag) was digested with DNase (GIBCO)
at room temperature (RT) for 15 min. Digested RNA was
reverse transcribed at 42 jC for 30 min (Reverse Transcrip-
tion System, Promega). Amplification was performed for
eNOS, iNOS, and GAPDH as standard, using the following
primer sequences: eNOS (s), 5V-CCA GCTAGC CAA AGT
CACCAT-3V; eNOS (as), 5V-GTCTCGGAGCCATACAGG
ATT-3V; iNOS (s), 5V-CGC CCT TCC GCA GTT TCT-3V;
iNOS (as), 5V-TCC AGG AGG ACA TGC AGC AC-3V;
GAPDH (s), 5V-TCA CCA TCT TCC AGG AGC GA-3V;
GAPDH (as), 5V-CAC AAT GCC GAA GTG GTC GT-3V.
PCR was carried out in a final volume of 20 Al, with 1
Al cDNA, 200 AM dNTP, 1 U Taq polymerase (Perkin
Elmer) and 10 pmol of each oligonucleotide primer. PCR
for GAPDH was performed for 22 cycles with an initial
denaturation at 94 jC for 2 min and cycling times of 30 s at
94 jC, 30 s at 62 jC, and 30 s at 72 jC. PCR’s for eNOS,
iNOS were performed with annealing temperatures of 58 jC
and with 35, 30 cycles, respectively. Following amplifica-
tion, PCR products were analyzed in 2% agarose gels
containing ethidium bromide. PCR bands were measured
and compared with Chemi Doc System (Bio-Rad).
2.15. Statistical methods
Eight experiments were included into each group. Data
are meanF standard error (S.E.). Groups were compared
using the two-tailed Student’s t-test for unpaired samples
with Bonferroni correction for multiple testing. Statistical
significance was assumed at P < 0.05.3. Results
3.1. Ventilation, pulmonary artery pressure and vascular
permeability
The upper panel of Fig. 1 represents the PIP during the
entire 135-min recording time. There were no changes within
the individual groups throughout the time of the experiment.
Expectedly, PIP of the LVZP group and HVZP group
differed significantly in accordance with Vt. As had been
intended, the choice of ventilatory patterns led to a PIP in the
LV5P group that was similar to that of the HVZP group.
Pressure–volume curves (data not shown) of the three
experimental groups at 135 min were not different compared
with those from a separate set of lungs which were recorded
immediately after preparation and warm up. We therefore
conclude that lung mechanics were not altered by the
ventilation patterns used in this model during the entire
experimental time period of 135 min.
The lower panel of Fig. 1 depicts PAP, which remained
unaltered in all experimental groups during the entire
recording time of 135 min. There were only minor differ-
ences in PAP among the groups. Capillary filtration coeffi-
Fig. 2. BAL fluid total phospholipid concentration of the three different
experimental groups was measured using the colorimetric method described
by Stewart [28]. (*) Indicates P < 0.05 level of significance in comparison
with the LVZP group and the LV5P group (t-test for unpaired samples).
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(as parameters of vascular permeability) and vascular com-
pliance are summarized in Table 1. We observed no signif-
icant differences of these parameters among the groups.
Total fluid retention, which represents the increase in lung
weight during the entire experiment was 6.8F 1.7, 5.7F 1.9
and 6.2F 1.5 g in the LVZP, LV5P and HVZP groups,
respectively. These results confirmed that the chosen venti-
latory patterns did not induce changes in lung mechanics,
vascular tone or vascular permeability during the entire
experimental period.
3.2. LDH release
LDH activity in the perfusate did not increase with time
in any of the three groups. In addition, there were no
significant differences among groups. BAL-LDH activity
averaged 5.1F 0.36, 5.9F 0.55 and 8.35F 2.5 U/l in the
LVZP, LV5P and HVZP groups, respectively. Although
these values did not reach the level of statistical signifi-
cance, they may indicate a tendency to increased LDH
release in the high Vt group.
3.3. BAL fluid phospholipids
BAL fluid phospholipid concentration (Fig. 2) was
significantly elevated in BAL fluid of the HVZP group in
comparison with BAL fluid of the low Vt groups.
The 31P-NMR spectra of the organic extracts of the BAL
fluids (Fig. 3) also reflect the differences in total phospho-
lipid concentration among the experimental groups. The
assignment of resonances has previously been described
[31]. Quantitative analysis of the 31P-NMR spectra of the
organic extracts of the BAL fluids did not reveal any
differences in the relative content of the phospholipid
species among the three groups. We also did not observe
any differences in the PG/PC ratio (LVZP: 0.082F 0.015;
LV5P: 0.084F 0.0027; and HVZP: 0.099F 0.0095).Table 1
Results of hydrostatic challenges
Time  15 30
Kf,c LVZP 0.73F 0.15 0.76F 0.15
LV5P 0.99F 0.16 0.95F 0.23
HVZP 0.71F 0.19 0.68F 0.18
DW LVZP 0.92F 0.10 0.94F 0.17
LV5P 1.6F 0.55 1.6F 0.42
HVZP 0.81F 0.23 1.4F 0.40
C LVZP 0.36F 0.032 0.34F 0.020
LV5P 0.39F 0.036 0.38F 0.036
HVZP 0.35F 0.030 0.38F 0.031
Hydrostatic challenges (sudden increase in venous pressure of 10 mbar over 8 m
before start of the experiments and at 30, 60, 90 and 120 min during the e
H2O
 1 g 1]), fluid retention—i.e. difference in lung weight before and after t
H2O
 1]) are calculated from the lung weight registration during the hydrostaticThis lack of a difference in phospholipid composition
was confirmed by mass spectrometry. MALDI-TOF mass
spectrometry was used for this investigation because this
method is highly sensitive and less time-consuming com-
pared to, e.g. thin layer chromatography. The positive (left)
and negative ion (right) MALDI-TOF mass spectra allowing
sufficient differentiation of the most relevant phospholipid
species of BAL fluid are presented in Fig. 4. Positive ion
spectra are primarily dominated by phosphatidylcholines
(706.6: PC 14:0/16:0 + H+, 734.6: PC 16:0/16:0 + H+,
758.6: PC 16:0/18:2 +H+, PC 760.6: 16:0/18:1 +H+) as
well as the corresponding sodium adducts (756.6: PC
16:0/16:0 +Na+, 780.6: PC 16:0/18:2 +Na+, 782.6: 16:0/
18:1 +Na+). Even if peak assignment is ambiguous in a few
cases, this problem can be overcome by addition of a large
excess of CsCl (data not shown). This has been demonstrat-
ed previously with phospholipids as well as lipoproteins
derived from blood [32]. Minor peaks at lower m/z ratios are
caused by lyso-phosphatidylcholine 16:0 and the cor-
responding sodium adduct (496.3: lyso-PC 16:0 + H+,60 90 120
0.75F 0.16 0.83F 0.21 0.87F 0.23
0.97F 0.17 0.86F 0.17 0.96F 0.90
0.76F 0.13 0.78F 0.22 0.94F 0.33
0.91F 0.21 1.4F 0.41 1.84F 0.80
1.5F 0.32 1.8F 0.57 2.23F 0.47
1.3F 0.31 1.7F 0.64 1.8F 0.67
0.34F 0.026 0.34F 0.035 0.35F 0.037
0.40F 0.041 0.40F 0.040 0.41F 0.040
0.39F 0.021 0.39F 0.028 0.39F 0.040
in) were performed under baseline conditions (t = 15 min) immediately
xperiment. Capillary filtration coefficient (Kf,c; [10
 4 cm3 s 1 cm
he hydrostatic challenge (DW; [g])—and vascular compliance (C; [g cm
challenge. These data are summarized in this table.
Fig. 4. Positive (left) and negative ion (right) MALDI-TOF mass spectra of organic extracts of BAL fluid. Representative spectra of each experimental group
are compared (same BAL as in Fig. 6). Peaks are labelled with respect to their m/z ratio.
Fig. 3. 31P NMR spectra of organic extracts of BAL fluids recorded in aqueous sodium cholate. Representative spectra of each experimental group are
compared. The different phospholipid classes are indicated by the following abbreviations: PC, phosphatidylcholine; PG, phosphatidylglycerol; PI,
phosphatidylinositol; SM, sphingomyelin; PE, phosphatidylethanolamine; PA, phosphatidic acid. Inorganic phosphate is characterized by Pi. The (*) indicates
di-lauroyl-phosphatidic acid (PA 12:0/12:0), which was used as an internal standard (final concentration, 47.2 AM).
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Fig. 6. iNOS and eNOS gene expression measured by RT-PCR: results of
semiquantitative PCR for eNOS, iNOS and GAPDH are shown. PCR
products from a single experiment of each experimental group are shown.
These results are representative for the RT-PCR of all experiments. The
density of the bands are depicted in the lower part of the figure.
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the negative ion spectrum were those of the phosphatidyl-
glycerol classes (721.6: PG 16:0/16:0; 747.6: PG 16:0/18:1)
and the phosphatidylinositol classes (835.6: PI 16:0/18:1,
861.6: PI 18:0/18:2, 885.6: PI 18:0/20:4). Other acidic
phospholipids yielded signals close to the noise level and
were, therefore, not assigned. As has been reported previ-
ously, phosphatidylethanolamines in the presence of higher
amounts of phosphatidylcholine are not detectable using
MALDI-TOF mass spectrometry [31].
In summary, we observed an increase in total phospho-
lipid concentration in the HVZP group in comparison to the
other two groups. However, none of the three groups was
different with respect to the relative concentration of the
surfactant phospholipid species as measured quantitatively
by 31P-NMR spectroscopy. Phospholipid classes were also
qualitatively identical in all three experimental groups.
Because desorption techniques are all characterized by
varying sensitivities towards individual lipid classes, accu-
rate quantification is difficult when MALDI-TOF mass
spectrometry is used [33].
3.4. Vascular and alveolar NO release
As indicated in Fig. 5, nitrite concentration in the
perfusate did not differ among the three experimental
groups. However, BAL fluid nitrite concentrations wereFig. 5. Perfusate (upper panel) and BAL fluid (lower panel) nitrite
concentration at the end of the experiments were measured using the Griess
reagent method. (*) Indicates P< 0.05 level of significance in comparison
with the LVZP group and the LV5P group (t-test for unpaired samples).significantly elevated in the HVZP group in comparison
with both of the low Vt groups.
3.5. eNOS and iNOS RT-PCR
Gene expression of eNOS, iNOS and GAPDH were
measured by use of semiquantitative PCR. The PCR prod-
ucts of a representative lung of each group are presented in
Fig. 6. The iNOS signal did not differ largely among the
three experimental groups. The eNOS signal is slightly
lower in the LV5P group in comparison with the LVZP
group and markedly reduced in the HVZP group in com-
parison with both of the low Vt groups. The PCR results
depicted in Fig. 6 are representative for RT-PCR analysis of
all lungs.
3.6. LPO products
Fig. 7 summarizes tissue LPO product concentration.
Because we did not detect LPO products using MALDI-Fig. 7. Tissue LPO product content (LPOt [nmol/mg tissue]): lung tissue
was taken at the end of experiments and analyzed for LPO products. (*)
Indicates P < 0.05 level of significance in comparison with the LVZP group
and the LV5P group (t-test for unpaired samples).
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spectrophotometric method was not performed.
Tissue LPO product concentration was significantly
increased in experiments with high Vt ventilation.4. Discussion
This study compares high Vt ventilation with low Vt
ventilation in an isolated rabbit lung model. Ventilation at
Vt = 6 ml/kg BW (LVZP) is compared with ventilation at
Vt = 12 ml/kg (HVZP). Because the two Vt result in differ-
ent PIP, a third ventilation pattern (LV5P) was chosen in
which Vt was kept at 6 ml/kg while PEEP was adjusted, so
that PIP was comparable to that in the 12 ml/kg (HVZP)
group. This resulted in a PEEP of 5 cm H2O. Thus the
effect of Vt was compared with and without the resulting
difference in PIP.
None of the three ventilatory patterns induced changes in
ventilatory mechanics, PAP and vascular permeability.
However, high Vt ventilation in comparison with low Vt
ventilation gave rise to increased alveolar nitric oxide
release—detectable as an increase in BAL fluid nitrite
concentration—and increased BAL fluid phospholipids
without obvious changes in phospholipid composition.
Increased BAL fluid phospholipid concentration in the
course of high Vt ventilation is also reported by another
study [34]. In our study, this effect was observed as being
independent from differences in PIP. Surfactant homeostasis
is maintained by alveolar type II cells. These cells release
surfactant phospholipids and proteins into the alveolus.
Several mechanisms contribute to increased BAL fluid
phospholipid concentrations: (i) secretion of phospholipids
from alveolar type II cells is regulated by many different
stimuli, most of them chemical agonists but also by phys-
iological stimuli such as mechanical stretch [14,35]. High in
comparison with low Vt ventilation results in greater disten-
sion of the alveoli. This will result in increased BAL fluid
phospholipid concentration as has been observed in this
study. (ii) Reduced re-uptake of surfactant phospholipids
that may be caused by a reduction of the number or function
of alveolar type II cells may also contribute to increased
BAL fluid phospholipid concentration.
Increased BAL fluid phospholipids, either due to high Vt
or due to exogenous substitution, may improve pulmonary
mechanics. However, surfactant substitution in the setting of
acute lung injury has also been shown to increase pulmo-
nary mediator release—possibly by recruiting lung to me-
chanical stress during ventilation [36]. Thus, we cannot
determine whether increased BAL fluid phospholipids in
our setting is beneficial or not.
In contrast with clinical observations in ARDS [12], we
did not find significant changes in phospholipid composi-
tion. This might be explained by the limited time frame of
isolated organ experiments that do not allow observation of
later stage VILI.Previous studies report a relation between pulmonary
nitric oxide release and mechanical stimuli [37,38]. This
supports our findings. The increased BAL fluid nitrite
concentration in high Vt ventilated lungs may be explained
as a result of greater alveolar distension due to high Vt.
Endothelial release of nitric oxide is predominately influ-
enced by shear stress [39]. Possibly the extent of alveolar
distension in the high Vt group was not enough as to induce
capillary deformation and increased shear stress. This notion
is supported by the lack of decrease in pulmonary vascular
resistance.
The biological function and the cellular source of disten-
sion-induced nitric oxide remain unclear. It has been
reported that nitric oxide protects alveolar type II epithelial
cells from apoptosis following mechanical overdistension
[40]. In addition, nitric oxide may induce a selective
pulmonary vasodilatation with improved perfusion of
well-ventilated alveoli, reduced intrapulmonary shunt vol-
ume and improved oxygenation [16,17]. This may explain
that despite differences in PIP, only slight differences in PAP
are found in the present study.
Endogenous nitric oxide has also been shown to aggra-
vate lung damage via peroxynitrite formation and radical
reactions [18,19,41]. This has been referred to as ‘‘nitrosative
stress’’. Both radicals, nitric oxide and peroxynitrite, might
induce LPO. We found increased LPO product accumulation
in lung tissue in the high Vt ventilation group. Although, in
the present study, cellular damage did not result in changes in
vascular permeability or pulmonary artery pressure, accu-
mulation of LPO products may be interpreted as an initial
step in the development of VILI. This conclusion is sup-
ported by clinical data, which show increased BAL fluid
nitrite and nitrate in patients with ARDS. Increased levels
have been related to increased mortality [20]. Although
BALF is considered to originate from the alveolar space,
airway epithelial cells may influence nitrite concentration of
the lavage fluid.
The amount of iNOS mRNA did not largely differ among
the three experimental groups. The eNOS mRNA level was
noticeably reduced in the group with the highest BAL fluid
nitrite concentration. The increased BAL fluid nitrite con-
centration in the HVZP group may not be explained by
differences in gene expression. NO synthesis, therefore,
may be regulated on the level of enzyme activity rather
than on the level of gene expression. It may be speculated
that the reduced eNOS mRNA level in the HVZP is due to a
negative feedback subsequent to the increased NO release in
this group.
In conclusion, high vs. low Vt ventilation resulted in the
following changes in this isolated lung model: increased
alveolar nitric oxide release and LPO product accumulation;
increased alveolar surfactant phospholipid pool. These
consequences of high Vt ventilation were not influenced
by a considerable difference in PIP and PEEP but were due
to the difference in the size of Vt. Although high Vt
ventilation did not induce overt acute lung injury detectable
S. Hammerschmidt et al. / Biochimica et Biophysica Acta 1639 (2003) 17–26 25as an increase in PAP or vascular permeability, it did result
in changes that may either reflect mechanisms of adaptation
to increased mechanical stress or else be part of early
injurious processes.Acknowledgements
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